Navigation Links
Concerned Stockholders Launch Save Vermillion! Website:

PHILADELPHIA, Feb. 1, 2013 /PRNewswire/ -- George Bessenyei , Gregory V. Novak , and Robert S. Goggin (the "Group") today launched their website,, to provide all stockholders access to relevant information concerning Vermillion Inc.'s (the "Company" or "Vermillion") contested 2012 Annual Stockholder meeting (the "2012 Annual Meeting").

The road to forcing Vermillion's Board to schedule the annual meeting has been anything but easy, short, or smooth.  Almost a year ago, on February 15, 2012, the Group announced its intention to nominate Robert S. Goggin as Director Nominee for the 2012 Annual Meeting. After a series of dodge ball tactics by the Board and Gail Page , more recently, on January 9, 2013, Bessenyei filed a complaint in the Delaware Chancery Court ("Court"), asking the Court to order the Company to call and hold an annual meeting of stockholders at the earliest practicable date. This maneuver was necessary, given what the Group believes was management's stonewalling, to finally force the Company to abide by its own Bylaws, Delaware law and to avoid a NASDAQ delisting process, and call the 2012 meeting.  After the complaint was filed, the Company finally set the meeting date for March 21st, 2013.

In order to provide more information to stockholders, the Group today launched its website. Major topics include: 

  • Robert S. Goggin 's Five Point Turnaround Plan for Vermillion
  • Comprehensive analysis of OVA1 and its market potential
  • Biography of Group members
  • Timeline of events leading to the 2012 Annual Meeting
  • Compensation counter tracking the benefits provided to Vermillion Directors over the past several years, currently standing at a staggering $13,176,632
  • The Reverse Midas Touch: Chairman James S. Burns ' track record at public companies*

Visit our webpage today!

The Group's proxy statement (the "Group Proxy Statement"), filed on January 29, 2013, is available free of charge at  The Group Proxy Statement will first be sent or given to stockholders on or about February 6, 2013.  Stockholders are advised to read the Group Proxy Statement and the other documents relating to the Group's solicitation of proxies by members of the Group from stockholders of the Company for use at its 2012 Annual Meeting because they contain important information.

*( James S. Burns serves as Chairman of the Board at Vermillion; he is also a Director at Symmetry Medical, Inc. and Chief Executive Officer at AssureRx Health, Inc.)

Stockholders please contact Okapi Partners LLC
Patrick McHugh / Geoff Sorbello
(212) 297-0720

Concerned Vermillion Stockholders
T: 561-444-8180

SOURCE Concerned Vermillion Stockholders
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Mangrove Partners Sends Letter to Stockholders of Nabi Biopharmaceuticals
2. Bacterin Receives Letter From NYSE MKT LLC Regarding Timely Notice of Record Date for 2012 Annual Meeting of Stockholders
3. Generex Announces Date of Annual Stockholders Meeting
4. Amarantus BioScience Launches New Website
5. Touch Medical Media Splits From Touch Briefings, Launches a Series of Cutting Edge, Free to Access, Educational Resources and Signs an Updated Media Partnership With ECCO, The European CanCer Organisation Representing 60,000 Oncology Professionals
6. Find New Cancer Treatments at cureLauncher
7. New York Microscope Launches New Website
8. MDA Launches Clinical Network to Speed Myotonic Dystrophy Research
9. DuPont Pioneer Launches Next Generation T Series Soybeans
10. Launches New Site Design for 2013, Slick New Interface Impresses
11. Nerium Announcing Launch of New Blog Sites
Post Your Comments:
(Date:6/24/2016)... ... 2016 , ... While the majority of commercial spectrophotometers and fluorometers use the ... models are higher end machines that use the more unconventional z-dimension of 20mm. ... the bottom of the cuvette holder. , FireflySci has developed several Agilent flow ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
Breaking Biology Technology:
(Date:6/2/2016)... Perimeter Surveillance & Detection Systems, ... Infrastructure, Support & Other Service  The latest ... comprehensive analysis of the global Border Security market ... of $17.98 billion in 2016. Now: In ... in software and hardware technologies for advanced video surveillance. ...
(Date:5/12/2016)... , May 12, 2016 , ... published the overview results from the Q1 wave of ... recent wave was consumers, receptivity to a program where ... with a health insurance company. "We were ... share," says Michael LaColla , CEO of Troubadour ...
(Date:4/26/2016)... and LONDON , April ... part of EdgeVerve Systems, a product subsidiary of ... today announced a partnership to integrate the Onegini ...      (Logo: ) ... their customers enhanced security to access and transact ...
Breaking Biology News(10 mins):